Introduction {#s1}
============

Inside cells, proteins are assembled into complex functional units. The correct assembly of these units is crucial for their function ([@bib41]). Myofibrils are highly organized assemblies of cytoskeletal proteins forming an array of sarcomeres that are embedded in the cytosol of myotubes and mediate contractility ([@bib27]; [@bib26]; [@bib25]; [@bib33]). Sarcomeres are composed of actin-containing thin filaments and myosin-containing thick filaments arranged into antiparallel cables. Thin filaments are anchored to a large multiprotein complex called the Z-disc ([@bib38]), and thick filaments are anchored to another large multiprotein complex called the M-line ([@bib2]). Anchoring of myofibrils to the exoskeleton provides the mechanical tension that aligns sarcomeres into myofibrils and coordinates their development ([@bib66]; [@bib65]). Once aligned, sarcomeres grow to their final size ([@bib33]). Electron and confocal microscopy studies showed that sarcomeres form initially from small structures called Z-bodies that grow eventually into mature Z-discs to which thin filaments are anchored ([@bib37]; [@bib44]; [@bib47]; [@bib54]; [@bib56]). The size of the Z-disc therefore sets the diameter of the myofibril ([@bib2]; [@bib38]). While mechanisms have been proposed that set the length of sarcomeres ([@bib17]; [@bib21]; [@bib61]), Z-disc growth and growth termination is poorly understood.

A hallmark of genetically caused myopathies is the appearance of large aggregates composed mainly of Z-disc proteins ([@bib32]; [@bib39]). Interestingly, many myopathy-associated mutations encode Z-disc proteins. Mutations in any of the four α-actinin genes or in Zasp and other Alp/Enigma family genes in humans cause myopathies characterized by the presence of large aggregates ([@bib43]; [@bib53]). The aggregation phenotype is conserved among animals: fruit flies with mutations in myopathy-related genes also develop Z-disc aggregates ([@bib22]).

α-Actinin and [Z]{.ul}-disc [A]{.ul}lternatively [S]{.ul}pliced [P]{.ul}rotein (Zasp) are conserved proteins that coordinate Z-disc formation ([@bib15]; [@bib29]; [@bib43]). α-Actinin forms a rod-shaped antiparallel homodimer at the Z-disc, where it crosslinks and serves as an attachment point for actin filaments ([@bib13]; [@bib38]; [@bib43]; [@bib48]; [@bib49]; [@bib59]). Zasp and other members of the Alp/Enigma family of proteins are scaffolding proteins with an α-actinin-binding PDZ domain (InterPro: IPR001478), an uncharacterized [Z]{.ul}asp [M]{.ul}otif (ZM; InterPro: IPR031847 and IPR006643) domain, and one to four protein-protein interaction LIM domains (InterPro: IPR001781) ([@bib18]; [@bib30]; [@bib36]). Zasp and α-actinin proteins are present at the earliest stages of Z-disc formation, and are required for Z-disc assembly ([@bib12]; [@bib29]).

Vertebrates have seven Alp/Enigma genes, each encoding several isoforms. The *Drosophila* genome has three Zasp genes, *Zasp52*, *Zasp66*, and *Zasp67*, which encode 21, 12, and 4 isoforms, respectively ([@bib24]). Zasp66 and Zasp67 are duplications of Zasp52 and resemble the smallest isoforms of Zasp52 ([@bib23]). The number of isoform variants and genes adds an additional layer of complexity and regulation to sarcomere formation.

We used *Drosophila* indirect flight muscles and asked if the mechanism that controls Z-disc size relates to the pathological aggregation behavior known for Z-disc-related myopathies. We show that accumulation of multivalent Zasp growing isoforms (with multiple LIM domains) causes Z-disc growth, whereas upregulation of monovalent blocking isoforms at later developmental time points terminates Z-disc growth. An imbalance of growing and blocking Zasp isoforms results either in aggregate formation, enlarged Z-disc size or reduced Z-disc size. We propose that this mechanism has wide implications for diseases caused by aggregate formation.

Results {#s2}
=======

Aggregate formation upon Zasp overexpression {#s2-1}
--------------------------------------------

Dominant Zasp mutations cause aggregate formation in human myopathies ([@bib53]). To examine if this holds true in *Drosophila*, we overexpressed a full-length Zasp52-PR transgene consisting of a PDZ, a ZM, and 4 LIM domains in the indirect flight muscles (IFM) of adult flies, which causes formation of large aggregates ([Figure 1A,B,I](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). To determine which domain is responsible for aggregation, we deleted them individually: the absence of LIM domains (Zasp52-PP) and ZM domain (Zasp52-PR∆ZM) abolished aggregate formation, whereas removal of the PDZ domain only slightly reduced the number of aggregates (Zasp52-PR∆PDZ, [Figure 1C--E,I](#fig1){ref-type="fig"}). The PDZ domain is required for binding α-actinin, a crucial crosslinker of actin filaments at the Z-disc ([@bib29]; [@bib36]). Reducing α-actinin levels by RNAi in Zasp52-PR overexpression reduces aggregate formation to a similar level ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}), indicating that α-actinin increases aggregate number, but is not required for their initial formation. Expression of the paralogous genes Zasp66 and Zasp67 ([@bib23]), which lack LIM domains like Zasp52-PP, also does not result in aggregate formation ([Figure 1F,G and I](#fig1){ref-type="fig"}). Finally, we tested if multiple LIM domains are required for aggregate formation by overexpressing Zasp52-PK consisting of PDZ, ZM and 1 LIM domain. No aggregates form ([Figure 1H and I](#fig1){ref-type="fig"}) indicating that the ZM domain and multiple LIM domains are required for aggregate formation.

![Aggregate formation upon Zasp overexpression.\
(**A--H**) Confocal images of IFM in control or Zasp overexpression conditions using Act88F-Gal4; actin filaments are marked in magenta and Z-discs in green. (**A**) In control flies, sarcomeres are regular with Z-discs located in the center of the actin signal. (**B**) Upon GFP-Zasp52-PR overexpression sarcomere structure is severely affected and big Zasp aggregates appear. (**C**) The overexpression of Flag-Zasp52-PP, an isoform lacking all LIM domains, has a modest sarcomere phenotype and aggregation is not observed. (**D**) Overexpression of a mutated form of Zasp52-PR with a deletion in the ZM domain does not form aggregates. (**E**) Overexpression of a mutated form of Zasp52-PR carrying a deletion in the PDZ domain causes small aggregates and sarcomere phenotypes. (**F and G**) The overexpression of the other Zasp paralogs, Zasp66 or Zasp67, does not cause aggregates. (**H**) Overexpression of GFP-Zasp52-PK, a smaller isoform of Zasp52 lacking LIM2, 3, and 4 domains affects sarcomere structure, but aggregation is infrequent. (**I**) Estimation of Z-disc aggregates in all overexpression conditions, n = 10 muscle fibers. (**J**) Confocal images of IFM in control or in mild overexpression of GFP-Zasp52-PR using UH3-Gal4. (**K**) Estimation of Z-disc aggregates in mild overexpression of GFP-Zasp52-PR. (**L**) Frequency plot of Z-disc sizes. Z-discs are bigger when GFP-Zasp52-PR is overexpressed using UH3-Gal4. Scale bars, 10 µm. p-Values in panel I and K were calculated using Welch's two-sample t-test.\
Figure 1---source data 1.Aggregate frequency estimates in Zasp overexpressions.](elife-50496-fig1){#fig1}

To test if aggregates formed as a result of Z-disc overgrowth, we tested the overexpression of Zasp52-PR using UH3-Gal4, a driver line that has the same temporal and spatial expression pattern as Act88-Gal4 but is expressed at a much lower level. To better capture the size variation, we measured the Z-disc height that corresponds to the disc diameter and categorized them into specific size categories. In this condition, Z-discs are bigger than the control, but aggregates are not present ([Figure 1J--L](#fig1){ref-type="fig"}), indicating that Z-disc growth and pathological aggregation correlate with the amount of Zasp52 protein.

Domains required for Zasp self-interaction {#s2-2}
------------------------------------------

Next, we employed the yeast two-hybrid system (Y2H) to determine if Zasp forms oligomers by interacting with itself. Zasp52-PK and Zasp52-PE, another full-length isoform, can interact with each other, whereas controls do not interact ([Figure 2A](#fig2){ref-type="fig"}). Full-length isoforms of Zasp66 and Zasp67 (Zasp66-PK and Zasp67-PD) can also interact with Zasp52-PK and Zasp52-PE ([Figure 2A](#fig2){ref-type="fig"}). These data suggest that Zasp proteins can homo- and heterodimerize.

![Y2H assays reveal domains involved in homo/heterodimerization.\
(**A**) Yeast two-hybrid assays between the three Zasp paralogs. Images of double-transformed yeast grown in selective -Ade/-His/-Leu/-Trp plates. Serial dilutions are shown from left to right (OD: 0.1, OD: 0.01, and OD: 0.001). Zasp52-PK dimerizes with itself and with the longer isoform Zasp52-PE. Zasp66 interacts with Zasp52-PK and Zasp52-PE. Zasp67 interacts with Zasp52-PK and Zasp52-PE. Negative controls using the DNA-binding domain (bait, pGAD-T7) or the Activating domain of Gal4 (prey, pGBK-T7) are shown. (**B**) Y2H assays testing the interaction between all protein domains encoded by the Zasp52 gene and Zasp52-PK, Zasp66-PK, or Zasp67-PD proteins. Zasp52-PK interacts with isolated ZM and LIM domains, Zasp66-PK and Zasp67-PD interact only with some LIM domains. LIM1A, LIM1B, LIM2A, and LIM2B are different splice isoforms of LIM1 and LIM2 domains. (**C**) Proposed model of Zasp homo/heterodimerization. The LIM domains bind the ZM domain. Zasp52-PK dimerization occurs through two ZM/LIM pairs. The heterodimerization between Zasp52-PK and Zasp66-PK or Zasp67-PD occurs through only one ZM/LIM-binding site. Zasp66-PH is a small isoform that only contains a ZM domain. (**D**) Y2H assays mapping the interaction between different Zasp52 LIM domains to Zasp66-PK using truncation mutants. (**E**) Y2H assays testing the interaction between the ZM only isoform Zasp66-PH, and the individual protein domains encoded by Zasp52.](elife-50496-fig2){#fig2}

We confirmed these results by co-immunoprecipitation of Flag-tagged Zasp52 with GFP-tagged Zasp52 from thorax muscle extracts ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). Furthermore, bacterially purified His-Zasp52-PK-Flag dimerized in vitro in a chemical crosslinking assay ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}).

To identify the domains involved in homo- and heterodimerization, we tested the interaction of Zasp52-PK, Zasp66 and Zasp67 with each individual domain of Zasp52. Zasp52-PK interacts with the ZM domain and LIM domains, whereas Zasp66 and Zasp67 only interact with LIM domains ([Figure 2B](#fig2){ref-type="fig"}). This suggests that dimerization is mediated by a ZM-LIM domain interaction, and because Zasp66 and Zasp67 lack LIM domains, they cannot interact with the ZM domain ([Figure 2C](#fig2){ref-type="fig"}). To confirm this hypothesis, we next tested the interaction of LIM2A, LIM2B, LIM3 and Zasp52-PK with a series of Zasp66 deletion constructs. As soon as the ZM domain of Zasp66 is deleted, the interaction with LIM domains is abolished ([Figure 2D](#fig2){ref-type="fig"}). Finally, we tested Zasp66-PH, a ZM-only isoform of Zasp66 for interaction with the individual domains of Zasp52. Zasp66-PH can only interact with LIM domains of Zasp52 ([Figure 2E](#fig2){ref-type="fig"}). Thus, LIM-ZM binding mediates homo- and heterodimerization between Zasp proteins.

Bimolecular fluorescence complementation reveals Zasp interaction at the Z-disc {#s2-3}
-------------------------------------------------------------------------------

Next, we investigated if LIM-ZM interaction observed in a heterologous system also occurs in vivo at the Z-disc. We hypothesized that an endogenous GFP-tagged Zasp66 will be recruited to the Z-discs by Zasp52. We analyzed two Zasp52 mutants that differentially affect sarcomere structure: *Zasp52^MI02988^* disrupts N-terminal isoforms and only partially affects the last three LIM domains, whereas *Zasp52^MI00979^* introduces a stop codon before the last three LIM domains ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}) ([@bib36]). Zasp66-GFP fluorescence is mildly reduced in *Zasp52^MI02988^* mutants ([Figure 3A,B and D](#fig3){ref-type="fig"}). In contrast, Zasp66-GFP fluorescence is strongly reduced in *Zasp52^MI00979^* mutants ([Figure 3C and D](#fig3){ref-type="fig"}), suggesting that Zasp52 recruits other Zasp proteins through its LIM domains, consistent with the Y2H results. α-Actinin localization at the Z-disc was not decreased in any of the Zasp mutants ([Figure 3---figure supplement 1B,C](#fig3s1){ref-type="fig"}).

![Zasp interaction in vivo at the Z-disc.\
(**A--C**) Confocal images of Zasp66-GFP IFM in control and *Zasp52* mutant backgrounds. Zasp66-GFP levels are lower in *Zasp52^MI00979^* mutant than in the control or in *Zasp52^MI02988^* mutants. (**D**) Boxplot of Zasp66-GFP intensities in control and *Zasp52* mutant backgrounds. (**E, F**) Examples of a negative BiFC control (**F**) and a positive BiFC signal (**E**) suggesting Zasp52-PK dimerizes at the Z-disc. (**G, H**) Plots of the BiFC fluorescence intensity values relative to background noise. Positive BiFC fluorescence is detected between Zasp52-PK and Zasp52-PK (**G**) and between Zasp52-PK and Zasp66-PH (**H**). Act88F-Gal4 was used to drive expression of NYFP- or CYFP-tagged proteins. Scale bar, 5 µm. p-Values in panels D, G, and H were calculated using Welch's two-sample t-test.\
Figure 3---source data 1.Zasp66 levels and BiFC values.](elife-50496-fig3){#fig3}

To determine if LIM and ZM domains directly interact in flies at the Z-disc, we employed bimolecular fluorescence complementation (BiFC) assays ([Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}) ([@bib10]; [@bib20]). We first confirmed that the ZM-only isoform Zasp66-PH fused to a Venus tag localized to Z-discs ([Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}). We then generated transgenic flies expressing Zasp52-PK and Zasp66-PH tagged with either the C-terminus or the N-terminus of yellow fluorescent protein (NYFP or CYFP) and quantified the fluorescence of reconstituted YFP at the Z-disc. Zasp52-PK-NYFP and Zasp52-PK-CYFP show specific fluorescence at the Z-disc, whereas controls do not ([Figure 3E--G](#fig3){ref-type="fig"}). More importantly, the ZM-only isoform Zasp66-PH-NYFP interacts specifically with Zasp52-PK-CYFP at the Z-disc ([Figure 3H](#fig3){ref-type="fig"}). Thus, ZM-LIM interaction of Zasp proteins occurs in vivo at the Z-disc.

ZM domains and canonical Z-discs co-appeared in bilateral animals {#s2-4}
-----------------------------------------------------------------

LIM domains are well-known protein-protein interaction domains ([@bib28]). In contrast, functional information on the ZM domain is scarce. It is an uncharacterized short motif of 26 amino acids found only in Alp/Enigma proteins ([@bib30]; [@bib34]). Alignment of *Drosophila* Zasp-encoding genes to the ZM consensus sequence shows weak conservation ([Figure 4A](#fig4){ref-type="fig"}). To determine the phylogenetic distribution of the ZM domain, we compiled the presence of ZM domains in all branches of metazoans using data from the PFAM database ([@bib4]; [@bib14]). In contrast to the universal presence of LIM domains in eukaryotes, the ZM domain is only present in a subset of animal genomes and absent from plants, fungi and unicellular metazoans ([Figure 4B](#fig4){ref-type="fig"}). Muscle striation evolved independently in cnidarians and bilaterians, with only the latter showing a canonical Z-disc structure ([@bib58]). Intriguingly, the ZM domain is restricted to bilateral animals ([Figure 4B](#fig4){ref-type="fig"}). Thus, our correlative data suggest that canonical Z-discs and ZM domains arose together during evolution.

![The evolution of the ZM domain.\
(**A**) Protein sequence alignment between the three Zasp paralogs in flies and the ZM consensus sequence SMART:SM00735. Similar amino acids to the consensus are highlighted in gray. (**B**) Radial phylogenetic tree of selected eukaryotic lineages with annotated presence of the ZM domain from the PFAM domain database (PFAM: PF15936). The ZM domain is restricted to bilateral animals.](elife-50496-fig4){#fig4}

Differential temporal expression and localization of Zasp growing and blocking isoforms {#s2-5}
---------------------------------------------------------------------------------------

Zasp isoforms can be divided into isoforms with multiple LIM domains (e.g. Zasp52-PR) and isoforms with just one or no LIM domain (e.g. Zasp52-PK, Zasp52-PP, Zasp66, Zasp67). We named the former growing isoforms and the latter blocking isoforms. We then considered what mechanism might coordinate Z-disc growth: we hypothesize that multiple LIM domain-containing Zasp proteins recruit other Zasp proteins by interacting with their ZM domains. If the recruited proteins are also multivalent (contain two or more LIM domains), more Zasp proteins will be recruited leading to Z-disc growth. However, if recruited proteins lack LIM domains, they block further recruitment of Zasp proteins, and Z-disc growth terminates ([Figure 5A](#fig5){ref-type="fig"}).

![Balance of ZM to LIM domains sets the diameter of the Z-disc.\
(**A**) Proposed model of Z-disc growth and aggregate formation. In nascent Z-bodies, Zasp binds α-actinin and forms a homodimer between its ZM and LIM domains. During the early growth phase, Zasp growing isoforms use their free LIM domains to recruit more Zasp molecules through the ZM domain, thus growing the Z-disc. At later stages, growth is downregulated by the incorporation of blocking isoforms of Zasp, which are recruited to the Z-disc but cannot recruit further proteins because they lack LIM domains. (**B**) RNAseq data plots showing the expression of selected Zasp isoforms at different developmental timepoints. The y-axis corresponds to the log of the number of transcripts per million (TPM) and the x-axis to hours after pupa formation. Isoforms were classified as blocking isoforms (0 or 1 LIM domain) or growing isoforms (two or more LIM domains). (**C**) Confocal microscopy image of IFM cross sections expressing Zasp52-GFP (green) and stained for actin (magenta). (**D**) Differential distribution of Zasp growing and blocking isoforms throughout the Z-disc. Images of false-colored denoised Z-discs. Zasp52-growing isoforms are more concentrated at the center of the disc, Zasp66 and Zasp67 are mostly concentrated in the periphery. Color scale is shown at the right. (**E**) Profile plots of relative intensity values at the Z-disc diameters from at least 10 individual Z-discs. Growing isoforms peak at the center of the Z-discs, blocking isoforms have two peaks. Scale bars in D, 1 µm.\
Figure 5---source data 1.Line intensity profile plots.](elife-50496-fig5){#fig5}

To regulate Z-disc growth, growing isoforms should be overrepresented at earlier stages of Z-disc formation, and blocking isoforms at later stages, to stop Z-disc growth. We used an RNAseq dataset from developing IFM that covers the whole Z-disc formation process, from 16 hr after puparium formation (APF) to newly eclosed flies ([@bib57]). We observed earlier expression of the growing isoforms compared to the blocking isoforms ([Figure 5B](#fig5){ref-type="fig"}). For example, multivalent Zasp52 growing isoforms are already strongly expressed at 24 hr APF, whereas some blocking isoforms without any LIM domains are expressed only after 60 hr APF ([Figure 5B](#fig5){ref-type="fig"}).

Z-discs grow at the periphery of the disc, starting as a small Z-body ([@bib44]; [@bib55]). Our model therefore predicts growing isoforms to be enriched at the centre and blocking isoforms to be enriched at the periphery of the final-sized Z-disc. To analyze the distribution of Zasp proteins within Z-discs, we made cross sections of myofibrils and evaluated the localization pattern of blocking isoforms (using Zasp66-GFP and Zasp67-GFP), and growing isoforms (using Zasp52-GFP; *Zasp52^ZCL423^)* at the level of the Z-disc. To label the entire disc, we used actin staining as counterstain ([Figure 5C](#fig5){ref-type="fig"}). To compensate for the low signal-to-noise ratio, we used a smoothening algorithm that takes advantage of the geometrical properties of discs ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Actin is evenly distributed in the Z-disc ([Figure 5D,E](#fig5){ref-type="fig"}). The growing isoforms are present throughout the disc, but most concentrated at the centre of the Z-disc ([Figure 5D,E](#fig5){ref-type="fig"}). The blocking isoforms Zasp66 and Zasp67 are partially excluded from the centre of the disc and form a ring-like pattern ([Figure 5D,E](#fig5){ref-type="fig"}). Zasp66 localizes more at the periphery compared to Zasp67, which correlates with its later expression peak compared to Zasp67 (middle panels of [Figure 5B](#fig5){ref-type="fig"}).

The balance between growing and blocking isoforms controls Z-disc growth and aggregation {#s2-6}
----------------------------------------------------------------------------------------

We then asked whether decreasing the levels of growing isoforms would result in smaller Z-discs. We measured individual Z-discs in control and *Zasp52* mutants ([Figure 6A--C](#fig6){ref-type="fig"}). Interestingly, only the *Zasp52^MI00979^* mutant, which deletes multiple LIM domains, had smaller Z-discs compared to the control ([Figure 6B,C](#fig6){ref-type="fig"}). In *Zasp52^MI00979^*, the smaller size categories were significantly elevated, whereas *Zasp52^MI02988^* was comparable to the control ([Figure 6C](#fig6){ref-type="fig"}).

![Balance of isoforms dictates Z-disc size.\
(**A and B**) Confocal microscopy images of control and *Zasp52^MI00979^* mutant. Actin filaments are marked in magenta and Z-discs in green. The *Zasp52^MI00979^* mutant has smaller and frayed Z-discs. (**C**) Frequency plot of Z-disc sizes in control, *Zasp52^MI02988^*, and *Zasp52^MI00979^* mutants. Small Z-discs are only observed in the *Zasp52^MI00979^* mutant. (**D**) Overexpression of the Zasp52-PP blocking isoform also results in smaller Z-discs. The small Z-disc phenotype is not observed in Zasp52-Stop143, lacking the ZM domain. (**E**) Small Z-disc phenotypes are observed upon overexpression of Zasp66 and Zasp67. (**F and G**) Boxplots of the Zasp52 fluorescence intensities upon overexpression of different blocking isoforms. (**F**) Zasp52-mCherry levels decrease upon overexpression of Zasp52-PP but are restored if the ZM domain of Zasp52-PP is deleted (Zasp52-\*143). (**G**) Zasp52-mCherry levels also decrease upon overexpression of Zasp66 and Zasp67. Act88F-Gal4 was used for overexpression experiments in panels D-G. Scale bars, 5 µm. p-Values in panels C-E were calculated using Fisher\'s exact test for count data. p-Values in panels F and G were calculated using Welch's two-sample t-test.\
Figure 6---source data 1.Z-disc diameter estimates and Zasp52 levels.](elife-50496-fig6){#fig6}

We next determined if the opposite approach, increasing the levels of blocking isoforms, also results in smaller Z-discs. Overexpressing the Zasp52-PP blocking isoform led to smaller Z-discs than the control ([Figure 6D](#fig6){ref-type="fig"}). This effect requires the ZM domain, because overexpression of Zasp52-Stop143 containing only a functional extended PDZ domain, causes a milder phenotype than Zasp52-PP ([Figure 6D](#fig6){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Like Zasp52-PP, overexpression of Zasp66 or Zasp67 resulted in smaller Z-discs ([Figure 6E](#fig6){ref-type="fig"}). We also confirmed these phenotypes by measuring the relative fluorescence of Zasp52-mCherry at the Z-disc. Upon overexpression of Zasp52-PP, but not of Zasp52-Stop143, Zasp52-mCherry recruitment to the Z-disc is reduced ([Figure 6F](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). Likewise, overexpression of Zasp66 and Zasp67 reduces Zasp52-mCherry recruitment to the Z-disc ([Figure 6G](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). In contrast, α-actinin levels were unchanged in Zasp overexpression conditions ([Figure 6---figure supplement 1B,C](#fig6s1){ref-type="fig"}). These data indicate that increasing the ZM/LIM ratio in IFM results in smaller Z-discs.

Finally, we wondered if depleting the blocking isoforms encoded by *Zasp66* and *Zasp67* can generate bigger Z-discs or aggregates using CRISPR *Zasp66* and *Zasp67* null mutants ([@bib23]). We observed rare aggregates in *Zasp66* and *Zasp67* single mutants ([Figure 7A,B,D](#fig7){ref-type="fig"}). As these two proteins likely have some redundant roles, we also analyzed the *Zasp66 Zasp67* double mutant, where we observed frequent aggregates ([Figure 7C,D](#fig7){ref-type="fig"}). Additionally, the single mutants had normal-sized Z-discs, whereas the double mutant had enlarged Z-discs ([Figure 7E](#fig7){ref-type="fig"}). Thus, blocking isoforms are required to prevent Z-disc overgrowth.

![Isoform imbalance leads to Z-disc aggregation.\
(**A--C**) Confocal microscopy images of *Zasp66* and *Zasp67* single null mutants and the *Zasp66 Zasp67* double mutant. Aggregates are outlined by a stippled red line. (**D**) Plot of aggregate frequencies of single and double mutants. (**E**) Frequency plot of Z-disc size categories in single and double mutants (for categories see [Figure 6](#fig6){ref-type="fig"}). (**F--H**) Confocal microscopy images of muscles overexpressing the growing GFP-Zasp52-PR isoform and selected Zasp blocking isoforms or a LacZ control. (**F**) In the control, GFP-Zasp52-PR overexpression produces aggregates. (**G**) The aggregation phenotype is suppressed by co-overexpression of the blocking isoform Zasp52-PP. (**H**) The aggregation phenotype is not rescued upon co-overexpression of Zasp52-Stop143, which lacks the ZM domain. (**I**) Aggregation frequency in different co-overexpression backgrounds. Act88F-Gal4 was used for overexpression experiments in panels F-I. Scale bars in A-C and F-J, 10 µm. p-Values in panel E were calculated using Fisher\'s exact test for count data. p-Values in panels D and I were calculated using Welch's two-sample t-test.\
Figure 7---source data 1.Z-disc diameter estimates and aggregate estimates.](elife-50496-fig7){#fig7}

As many diseases are believed to be caused by the formation of aggregates ([@bib3]; [@bib52]), we asked if we can suppress aggregate formation in our model of overexpressed GFP-Zasp52-PR ([Figure 1B](#fig1){ref-type="fig"}). Co-overexpression of both growing and the Zasp52-PP blocking isoform suppressed aggregate formation compared to a LacZ control ([Figure 7F--I](#fig7){ref-type="fig"}). The mutated blocking isoform Zasp52-Stop143 without the ZM domain did not suppress aggregation ([Figure 7H,I](#fig7){ref-type="fig"}). Co-overexpression of Zasp66 or Zasp67 also suppressed aggregation ([Figure 7I](#fig7){ref-type="fig"}).

Discussion {#s3}
==========

How myofibrils assemble and grow until they reach their final, highly invariant size has remained poorly understood. Here, we reveal a conserved mechanism by which the Z-disc scaffold protein Zasp oligomerizes to induce Z-disc and thereby myofibril growth. Furthermore, we show that Z-disc and sarcomere growth is terminated when shorter isoforms of Zasp are expressed that block multivalency-driven oligomerization.

Z-disc formation and growth is driven by multivalent oligomerization of Zasp proteins {#s3-1}
-------------------------------------------------------------------------------------

Our findings indicate that Z-disc formation and growth is driven by multivalent oligomerization of Zasp proteins with multiple LIM domains, and eventually terminated at the proper Z-disc size by the upregulation of blocking isoforms without LIM domains (see model in [Figure 5A](#fig5){ref-type="fig"}). The process of Z body and Z-disc formation is reminiscent of membraneless organelles with compositions distinct from the surrounding cytosol, which form through a mechanism of phase separation (e.g. Cajal bodies or P bodies) ([@bib6]; [@bib64]). Both have sharp boundaries between themselves and the cytoplasm, they form and organize as discrete puncta in the cytosol, and multivalent protein domains are often involved in their formation ([@bib35]; [@bib64]).

Sarcomere size is stereotyped in a given muscle type but distinct among different muscles ([@bib51]). How can our model explain differences in sarcomere sizes? The sarcomere grows, while the Zasp growing isoforms dominate the Zasp isoform pool. Different sarcomere sizes can be achieved in two ways. First, the sarcomere growth period -- the window of time in which Zasp growing isoforms dominate, might vary among muscle types. Second, the speed at which new Zasp molecules are recruited to the Z-disc, might be different among muscle types, while the growth period remains constant. Given the diversity of muscle types and therefore sarcomere sizes that exist, it is likely that a combination of these two strategies occur simultaneously.

Finally, apart from the ZM-LIM mechanism described here, additional redundant mechanisms to control Z-disc growth might exist, as evidenced by the observation that Zasp52-PR overexpression makes big Z-discs and aggregates, while the mutant removing Zasp52 LIM domains reduces Z-disc size to a comparatively small degree. Redundant mechanisms might operate through other LIM domain proteins, or the coordination of Z-disc and M-line growth, all of which may provide important buffering functions to ensure proper myofibril size, which is crucial for fully functional muscles.

The role of the ZM domain {#s3-2}
-------------------------

The ZM domain is a conserved domain without a clearly defined function. On its own, the ZM domain from two mouse Zasp proteins localizes to the Z-disc ([@bib30]; [@bib31]). Our data suggest that Z-disc localization is a conserved feature of ZM domains from vertebrates to insects. ZM-containing proteins are tethered to the Z-disc by the physical interaction with the LIM domains of other Zasp proteins. In sum, the LIM domain serves as a recruitment signal for Zasp proteins and potentially other unidentified ZM-containing proteins to join the Z-disc. In addition, given the appearance of the ZM domain in bilateral animals with canonical Z-discs, we postulate that a conserved mechanism involving LIM-ZM binding underlies Z-disc growth and growth termination.

Blocking and growing isoforms in vertebrates {#s3-3}
--------------------------------------------

In vertebrates, the Zasp proteins are very diverse and are better known as Alp/Enigma family: ZASP/Cypher/Oracle/LDB3/PDLIM6, ENH/PDLIM5, PDLIM7/ENIGMA/LMP-1, CLP36/PDLIM1/Elfin/hCLIM1, PDLIM2/Mystique/SLIM, ALP/PDLIM3, and RIL/PDLIM4. The ZM/DUF4749 motif occurs in ZASP, CLP36, PDLIM2, ALP and RIL ([@bib8]; [@bib11]; [@bib15]; [@bib62]; [@bib68]; [@bib69]). The LIM domain occurs in all Zasp proteins, either as one domain in Alp family members or as three domains in Enigma family members ([@bib68]). We identified two Zasp genes that encode only blocking isoforms in fruit flies: *Zasp66* and *Zasp67*, and one gene, *Zasp52*, that encodes blocking and growing isoforms. Although *Zasp66* and *Zasp67* genes are insect-specific ([@bib23]), vertebrate Alp/Enigma genes also express isoforms without LIM domains that could fulfill a blocking isoform function ([@bib9]; [@bib68]). In addition, because Zasp52-PK, which only contains one LIM domain, behaves as a blocking isoform, the Alp members with only one LIM domain might also behave as blocking isoforms.

The function of the growing isoforms of Zasp requires multiple functional LIM domains. As the Enigma family members contain three C-terminal LIM domains, they are the ideal candidates to fulfill the growing role in vertebrates. Three Enigma proteins exist in vertebrates: PDLIM7/Enigma/LMP-1, ENH/PDLIM5 and ZASP/Cypher/Oracle/LDB3/PDLIM6. Functional redundancy between them at the Z-disc is likely common and demonstrated in one case ([@bib42]). In Cypher knockout mice sarcomere assembly occurs normally during development, followed by immediate sarcomere failure after postnatal onset of contractility ([@bib69]). ENH mutants exhibit cardiac dilation and abnormal Z-disc structure in the heart ([@bib8]). Intriguingly, in both Cypher and ENH single mutants, as well as Cypher ENH double mutants, sarcomeres look considerably smaller in diameter in electron microscopy images ([@bib8]; [@bib42]; [@bib69]). Thus, a similar role for Enigma proteins in setting sarcomere diameter in vertebrates appears likely.

Sarcomere size control in human myopathies {#s3-4}
------------------------------------------

Is the mechanism that controls Z-disc size related to the protein aggregation defects in human myopathies? Our Z-disc oligomerization hypothesis agrees well with the observation that many myopathies present aggregates, and several human ZASP mutations have been linked to aggregate-forming myopathies ([@bib43]; [@bib53]). Many ZASP mutations linked to disease lie within the ZM domain or one of the LIM domains ([@bib53]; [@bib60]; [@bib63]). Protein aggregation in myopathy patients might be a consequence of an imbalance in the mechanism that controls sarcomere size, favoring the growing over the blocking isoforms. If this were the case, our data points to a potential therapeutic avenue: blocking the growing isoforms with short peptides containing a ZM domain.

In conclusion, we propose that a conserved mechanism involving LIM-ZM binding underlies Z-disc growth and therefore myofibril diameter.

Materials and methods {#s4}
=====================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                            Designation                                                                                      Source or\                                                                      Identifiers                                                      Additional\
  (species) or\                                                                                                                                             reference                                                                                                                                        information
  resource                                                                                                                                                                                                                                                                                                   
  -------------------------------------------------------- ------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------- ---------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------
  Gene (*Drosophila melanogaster*)                         Zasp52                                                                                                                                                                           FBgn0265991                                                      

  Gene (*Drosophila melanogaster*)                         Zasp66                                                                                                                                                                           FBgn0035917                                                      

  Gene (*Drosophila melanogaster*)                         Zasp67                                                                                                                                                                           FBgn0036044                                                      

  Gene (*Drosophila melanogaster*)                         Actn                                                                                                                                                                             FBgn0000667                                                      

  Genetic reagent (*Drosophila melanogaster*)              *Act88F-Gal4*                                                                                    RM Cripps PMID: [22008792](https://www.ncbi.nlm.nih.gov/pubmed/22008792)        FBal0268407                                                      

  Genetic reagent (*Drosophila melanogaster*)              *UH3-Gal4*\                                                                                      Anja Katzemich PMID: [23505387](https://www.ncbi.nlm.nih.gov/pubmed/23505387)   FBti0148868                                                      
                                                           (*P\[GawB\]HkUH3*)                                                                                                                                                                                                                                

  Genetic reagent (*Drosophila melanogaster*)              *UAS-LacZ*                                                                                       BDSC                                                                            RRID:[BDSC_3356](https://scicrunch.org/resolver/BDSC_3356)       

  Genetic reagent (*Drosophila melanogaster*)              *UAS-GFP-Zasp52-PR*                                                                              Current study                                                                   N/A                                                              Expresses full length Zasp52-PR isoform with a N terminal GFP tag under UAS. The landing site is ZH-attP-86Fb.

  Genetic reagent (*Drosophila melanogaster*)              *UAS-GFP-Zasp52-PK*                                                                              Current study                                                                   N/A                                                              Expresses Zasp52-PK isoform with a N terminal GFP tag under UAS. The landing site is ZH-attP-86Fb.

  Genetic reagent (*Drosophila melanogaster*)              *UAS-Flag-Zasp52-PR*                                                                             Kuo An Liao PMID: [27783625](https://www.ncbi.nlm.nih.gov/pubmed/27783625)      FBal0323349                                                      Expresses full length Zasp52-PR isoform with a N terminal Flag tag under UAS. The landing site is ZH-attP-86Fb.

  Genetic reagent (*Drosophila melanogaster*)              *UAS-Flag-Zasp52-PR-ΔPDZ*                                                                        Kuo An Liao PMID: [27783625](https://www.ncbi.nlm.nih.gov/pubmed/27783625)      FBal0323350                                                      Expresses Full length Zasp52 without the PDZ domain and a N terminal Flag tag under UAS. The landing site is ZH-attP-86Fb.

  Genetic reagent (*Drosophila melanogaster*)              *UAS-Flag-Zasp52-PR-ΔZM*                                                                         Kuo An Liao PMID: [27783625](https://www.ncbi.nlm.nih.gov/pubmed/27783625)      FBal0323351                                                      Expresses full length Zasp52-PR isoform without the ZM domain and a N terminal Flag tag under UAS. The landing site is ZH-attP-86Fb.

  Genetic reagent (*Drosophila melanogaster*)              *UAS-Flag-Zasp52-PP*                                                                             Current study                                                                   N/A                                                              Expresses smallest Zasp52 isoform with a N terminal Flag tag under UAS. The landing site is ZH-attP-86Fb.

  Genetic reagent (*Drosophila melanogaster*)              *UAS-Flag-Zasp52-Stop143*                                                                        Current study                                                                   N/A                                                              Expresses Zasp52-PK isoform with a N terminal Flag tag and a stop codon at position 143 under UAS. The landing site is ZH-attP-86Fb.

  Genetic reagent (*Drosophila melanogaster*)              *UAS-Zasp66-PK-Flag-HA*                                                                          Current study                                                                   N/A                                                              Transgenic made from the UFO11045 plasmid from DGRC. The landing site is ZH-attP-58A.

  Genetic reagent (*Drosophila melanogaster*)              *UAS-Zasp67-PE-Flag-HA*                                                                          Current study                                                                   N/A                                                              Transgenic from Zasp67 sequence synthesized by Genscript and cloned into a pUASattb vector. The landing site is ZH-attP-58A.

  Genetic reagent (*Drosophila melanogaster*)              *Zasp52-MI02988-mCherry*                                                                         Nicanor Gonzalez-Morales\                                                       PMID: [29423427](https://www.ncbi.nlm.nih.gov/pubmed/29423427)   Replacement of the MIMIC02988 cassette in Zasp52 with an in-frame mCherry tag.
                                                                                                                                                            PMID: [29423427](https://www.ncbi.nlm.nih.gov/pubmed/29423427)                                                                                   

  Genetic reagent (*Drosophila melanogaster*)              *Zasp52-GFP Zasp52\[ZCL423\]*                                                                    BDSC                                                                            RRID:[BDSC_58790](https://scicrunch.org/resolver/BDSC_58790)     

  Genetic reagent (*Drosophila melanogaster*)              *Zasp66-GFP Zasp66\[ZCL0663\]*                                                                   BDSC                                                                            RRID:[BDSC_6824](https://scicrunch.org/resolver/BDSC_6824)       

  Genetic reagent (*Drosophila melanogaster*)              *Zasp67-GFP fTRG*                                                                                VDRC                                                                            v318355                                                          

  Genetic reagent (*Drosophila melanogaster*)              *UAS-Actn-KK (RNAi)*                                                                             VDRC                                                                            v110719; FBst0482284                                             

  Genetic reagent (*Drosophila melanogaster*)              *Zasp52\[MI02988\]*                                                                              BDSC                                                                            RRID:[BDSC_41034](https://scicrunch.org/resolver/BDSC_41034)     

  Genetic reagent (*Drosophila melanogaster*)              *Zasp52\[MI07547\]*                                                                              BDSC                                                                            RRID:[BDSC_43724](https://scicrunch.org/resolver/BDSC_43724)     

  Genetic reagent (*Drosophila melanogaster*)              *Zasp52\[MI00979\]*                                                                              BDSC                                                                            RRID:[BDSC_33099](https://scicrunch.org/resolver/BDSC_33099)     

  Genetic reagent (*Drosophila melanogaster*)              *Zasp66\[KO\]*                                                                                   PMID: [31123042](https://www.ncbi.nlm.nih.gov/pubmed/31123042)                  PMID: [31123042](https://www.ncbi.nlm.nih.gov/pubmed/31123042)   CRISPR null mutant of Zasp66

  Genetic reagent (*Drosophila melanogaster*)              *Zasp67\[KO\]*                                                                                   PMID: [31123042](https://www.ncbi.nlm.nih.gov/pubmed/31123042)                  PMID: [31123042](https://www.ncbi.nlm.nih.gov/pubmed/31123042)   CRISPR null mutant of Zasp67

  Genetic reagent (*Drosophila melanogaster*)              *UAS-Zasp66-PH-Venus*                                                                            Current study                                                                   N/A                                                              The Zasp66-PH isoform that contains only a ZM domain cloned into pBID-UAS-GV vector. The landing site is ZH-attP-58A.

  Genetic reagent (*Drosophila melanogaster*)              *UAS-Zasp66-PH-NYFP (CYFP)*                                                                      Current study                                                                   N/A                                                              The Zasp66-PH isoform fused to either NYFP or CYFP.

  Genetic reagent (*Drosophila melanogaster*)              *UAS-Zasp52-PK-NYFP (CYFP)*                                                                      Current study                                                                   N/A                                                              The Zasp52-PK isoform fused to either NYFP or CYFP.

  Recombinant DNA reagent                                  Plasmid: pGADT7                                                                                  Clontech                                                                        630442                                                           

  Recombinant DNA reagent                                  Plasmid: pBD-Gal4-Zasp67                                                                         DGRC                                                                            CT33772-BD                                                       

  Recombinant DNA reagent                                  Plasmid: pOAD-Zasp67                                                                             DGRC                                                                            CT33772-AD                                                       

  Recombinant DNA reagent                                  Plasmid: pENTRY-Zasp52-PK                                                                        DGRC                                                                            DGRC: GEO02280                                                   

  Recombinant DNA reagent                                  Plasmid: pENTRY-Zasp52-PE GEO12859                                                               DGRC                                                                            DGRC: GEO12859                                                   

  Recombinant DNA reagent                                  Plasmid: pENTRY-Zasp66-PH GEO14752                                                               DGRC                                                                            DGRC: GEO14752                                                   

  Recombinant DNA reagent                                  Plasmid: pGBKT7-GW                                                                               Addgene                                                                         61703                                                            

  Recombinant DNA reagent                                  Plasmid: pGADT7-GW                                                                               Addgene                                                                         61702                                                            

  Recombinant DNA reagent                                  Plasmid: pGADT7-Zasp66-PK                                                                        Current study                                                                   N/A                                                              Zasp66-PK isoform cloned into pGADT7.

  Recombinant DNA reagent                                  Plasmid: pGADT7-Zasp66-PK with stop codons                                                       Current study                                                                   N/A                                                              Stop codons were introduced in the Zasp66-PK-pGADT7 plasmid by site-directed mutagenesis (Genscript).

  Recombinant DNA reagent                                  Plasmid: pGBKT7- Zasp52 individual domains: PDZ, ZM, LIM1a, LIM1b, LIM2a, LIM2b, LIM3 and LIM4   Current study                                                                   N/A                                                              All individual domains of Zasp52 cloned into pGBKT7.

  Recombinant DNA reagent                                  Plasmid: pGBKT7GW-Zasp52-PK                                                                      Current study                                                                   N/A                                                              Zasp52-PK isoform cloned into pGBKT7GW using Gateway cloning.

  Recombinant DNA reagent                                  Plasmid: pGADT7GW-Zasp52-PK                                                                      Current study                                                                   N/A                                                              Zasp52-PK isoform cloned into pGADT7GW using Gateway cloning.

  Recombinant DNA reagent                                  Plasmid: pGBKT7GW-Zasp52-PE                                                                      Current study                                                                   N/A                                                              Zasp52-PE isoform cloned into pGBKT7GW using Gateway cloning

  Recombinant DNA reagent                                  Plasmid: pGADT7GW-Zasp52-PE                                                                      Current study                                                                   N/A                                                              Zasp52-PE isoform cloned into pGADT7GW using Gateway cloning.

  Recombinant DNA reagent                                  Plasmid: pGBKT7GW-Zasp66-PH                                                                      Current study                                                                   N/A                                                              Zasp66-PH isoform cloned into pGBKT7GW using Gateway cloning

  Recombinant DNA reagent                                  Plasmid: pGADT7GW-Zasp66-PH                                                                      Current study                                                                   N/A                                                              Zasp66-PH isoform cloned into pGADT7GW using Gateway cloning.

  Recombinant DNA reagent                                  Plasmid: pDEST- pUAS-RfB-HA-CYFP-attB                                                            Sven Bogdan PMID: [20937809](https://www.ncbi.nlm.nih.gov/pubmed/20937809)      FBrf0212496                                                      

  Recombinant DNA reagent                                  Plasmid: pDEST- pUAS-RfB-myc-NYFP-attB                                                           Sven Bogdan PMID: [20937809](https://www.ncbi.nlm.nih.gov/pubmed/20937809)      FBrf0212496                                                      

  Strain, strain background (*Saccharomyces cerevisiae*)   Matchmaker Y2HGold                                                                               Clontech                                                                        630498                                                           

  Strain, strain background (*E. coli*)                    BL21                                                                                             NEB                                                                             C2530H                                                           

  Antibody                                                 Anti-Flag                                                                                        SIGMA                                                                           F3165                                                            1:200

  Software, algorithm                                      R Project for Statistical Computing: base and ape packages                                       <https://cran.r-project.org/>                                                   RRID:[SCR_001905](https://scicrunch.org/resolver/SCR_001905)     

  Software, algorithm                                      Salmon                                                                                           <https://combine-lab.github.io/salmon/>                                         RRID:[SCR_017036](https://scicrunch.org/resolver/SCR_017036)     

  Software, algorithm                                      ImageJ/Fiji distribution                                                                         <https://fiji.sc/>                                                              RRID: [SCR_002285](https://scicrunch.org/resolver/SCR_002285)    

  Software, algorithm                                      Galaxy                                                                                           <https://usegalaxy.org/>                                                        RRID:[SCR_006281](https://scicrunch.org/resolver/SCR_006281)     

  Chemical compound, drug                                  ethylene glycol bis-sulfosuccinimidyl succinate (EGS)                                            Fisher Scientific                                                               21565                                                            

  Chemical compound, drug                                  YPDA medium                                                                                      Clontech                                                                        630464                                                           

  Chemical compound, drug                                  Minimal SD Base                                                                                  Clontech                                                                        630411                                                           

  Chemical compound, drug                                  -Leu /- Trp DO Supplement                                                                        Clontech                                                                        630417                                                           

  Chemical compound, drug                                  -Ade /- His /- Leu/-Trp DO Supplement                                                            Clontech                                                                        630428                                                           

  Chemical compound, drug                                  Acti-stain 488 phalloidin                                                                        CYTOSKELETON, INC                                                               PHDG1-A                                                          

  Chemical compound, drug                                  Alexa633-Phalloidin                                                                              Fisher Scientific                                                               A22284                                                           

  Chemical compound, drug                                  Rhodamine-phalloidin                                                                             Fisher Scientific                                                               10063052                                                         
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Experimental model {#s4-1}
------------------

We used *Drosophila melanogaster* as a model organism for most experiments. Fly stocks and crosses were raised at 25°C. A comprehensive list of all strains used and generated can be found in the Key Resources Table. We used *Saccharomyces cerevisiae* for the yeast two-hybrid assays. *Escherichia coli* BL-21 strain was used to express recombinant proteins.

Transgenic flies were generated by site-directed integration using the PhiC31 integrase method into either *M\[3xP3-RFP.attP\]ZH-58A*- or *M\[3xP3-RFP.attP\]ZH-86Fb*-bearing flies to ensure comparable expression levels ([@bib5]; [@bib40]). Unless stated otherwise, Act88F-Gal4 was used to drive strong transgene expression in the IFM ([@bib7]).

Yeast two hybrid and protein crosslinking assays {#s4-2}
------------------------------------------------

Partial or complete coding sequences for Zasp52, Zasp66 and Zasp67 were cloned into Y2H vectors either by PCR-ligase cloning or through Gateway cloning. Constructs and cloning details are listed in the Key Resources Table. All constructs were verified by sequencing. Selected constructs were transformed into the Matchmaker Y2H Gold strain using the lithium acetate method ([@bib19]). Double transformant colonies were selected and amplified in media lacking leucine and tryptophan (-Leu/-Trp). Serial dilutions of the selected double transformants were grown in plates lacking leucine, tryptophan, histidine and adenine (-Ade/-His/- Leu/-Trp) to test for protein-protein interactions. The experiments were done at least three times.

Recombinant 6xHis-Zasp52-PK-FLAG was expressed in *Escherichia coli* BL21 bacteria. Then, 6xHis-Zasp52-PK-FLAG was purified from the protein extracts using Ni-NTA agarose beads (Qiagen) for 3 hr at 4°C. The purified protein was then dialyzed overnight at 4°C. Finally, purified 6xHis-Zasp52-PK-FLAG was either incubated with ethylene glycol bis-sulfosuccinimidyl succinate (EGS) or alone. Then, the protein samples were analyzed by denaturing SDS-PAGE followed by western blotting with anti-Flag antibody (1:5000).

Muscle staining and microscopy {#s4-3}
------------------------------

The IFM were dissected as previously described ([@bib22]; [@bib67]). All images were acquired with comparable parameters. In agreement with previous studies, at least 10 thoraces were dissected for each condition. Samples were allocated into experimental groups according to their genotype. A big number of flies were collected for each experimental group and a subsample was randomly selected for dissection.

Bimolecular fluorescence complementation assay {#s4-4}
----------------------------------------------

Zasp52-PK, Zasp52-PE and Zasp66-PH Gateway pENTRY clones were obtained from the DGRC (GEO02280, GEO12859 and GEO14752). The BIFC pDEST vectors pUAS-RfB-HA-CYFP-attB and pUAS-RfB-myc-NYFP-attB vectors were a kind gift from Sven Bogdan ([@bib20]). Constructs were cloned using Gateway technology, and the final vectors were verified by sequencing. The Key Resources Table contains a list of transgenic flies used in this study.

The Act88F-Gal4 driver line was used to express CYFP- and NYFP-tagged proteins in the IFM. Then, the YFP fluorescence of individual Z-discs was quantified using the ImageJ plot profile tool ([@bib50]). At least 20 samples were used for each condition. The data was normalized to the basal noise levels and plotted in R software.

Image analyses {#s4-5}
--------------

To estimate the size of individual Z-discs and the fluorescence intensity levels of Z-disc proteins we first used a segmentation method that allows individual Z-discs to be measured ([@bib67]). Briefly, images from fluorescent Z-disc proteins were passed through a threshold filter, and then individual Z-discs were separated and measured using the analyze particles tool. Both tools can be found in any recent ImageJ/Fiji distribution ([@bib50]). To estimate the Z-disc size, we measured the Z-disc height, that corresponds to the disc diameter. Then, the data was analyzed and plotted in R software. To estimate the relative fluorescence intensities of Z-disc proteins, we first obtained the mean intensity raw values for each Z-disc. Then, we normalized the values to a control genotype. The resulting data was then analyzed in R software. Rare segmentation mistakes result from Z-discs that are in close proximity. We could filter these mistakes out by size exclusion in the control images, but not in mutant conditions. We decided to leave the segmentation mistakes for consistency. If anything, this method underestimates the size differences between control and mutants.

Batch Macro processing code for measuring individual Z-disc side-views in ImageJ`setAutoThreshold("Default dark");
run("Analyze Particles...", "size = 0.2 Infinity show = Outlines display exclude");`

To estimate the density of aggregates, present in a given IFM sample, we used confocal images of GFP- or mCherry-tagged Zasp. Each 36 × 36 µm image was divided into 256 2 × 2 µm images. An automatic threshold filter based on the original image was then used on the small images, and the area above the given threshold was measured. Then, we used R software to count the number of images with aggregates.

Batch Macro processing code for aggregation estimates in ImageJ`run("Montage to Stack...", "images_per_row = 16 images_per_column = 16 border = 0"); 
 macro "Measure Stack" {
saveSettings;
setOption("Stack position", true);
for (n = 1; n <= nSlices; n++) {
setSlice(n);
setAutoThreshold("Default dark stack");
//run("Threshold...");
run("Create Selection");;
run("Measure");
}
restoreSettings;
}`

Cross-section images of Z-discs {#s4-6}
-------------------------------

Thoraces of *Zasp52-GFP (Zasp52^ZCL423^), Zasp66-GFP (Zasp66^ZCL0663^), and Zasp67-GFP (Zasp67 ^fTRG^*) flies were fixed in paraformaldehyde and embedded into low-melting agarose blocks. Then, we sectioned the thoraces into 100-µm-thick sections using a standard vibratome. The sections were stained with TRITC-phalloidin and imaged using a LEICA SP8 confocal microscope and a 63x/1.4 oil objective. Images were then processed to isolate individual properly oriented Z-discs. To avoid artifacts from misoriented Z-discs, we selected only those in which the GFP signal coming from the Z-disc would cover the whole sarcomere area stained with phalloidin. To remove the background noise from cross-section Z-disc images, we took advantage of the geometrical properties of the Z-disc. We drew a selection circle around individual Z-discs and rotated the image by 2 degrees 180 times. Then, we calculated the average from all the rotated images.

We compared the Z-disc size categorical data using Fisher\'s exact test for count data, p-values above 0.001 were noted as not significant. We used Welch's two-sample t-test to compare the relative fluorescence intensities between groups. We used Welch's two-sample t-test to compare the aggregation frequency estimates.

Phylogenetic distribution of ZM domain proteins {#s4-7}
-----------------------------------------------

All species that contain at least one protein with either the ZM (PF15936) or the LIM (PF00412) domain were downloaded from the PFAM web ([@bib4]; [@bib14]). A general phylogenetic tree was plotted based on the NCBI taxonomy data ([@bib16]) using the *ape:plot.phyllo* tool ([@bib45]).

RNAseq analysis {#s4-8}
---------------

We uploaded all individual RNA-seq SRA reads from the project: PRJNA419412 (GEO: GSE107247) ([@bib57]). Each SRA read corresponds to a different time point in IFM development. We extracted the single-end reads using the fastq-dump tool. We then used Salmon v0.8.2 ([@bib46]) to quantify the expression of all transcripts as Relative Transcripts Per Million (TPM) values. We used all the cDNAs from the *D. melanogaster* r6 reference transcriptome in fasta format ([@bib1]). Then, the individual transcripts corresponding to the three Zasp genes were grouped according to their encoded protein domain architectures. Finally, we calculated the mean TPM values between similar isoforms and plotted the results over developmental time using R software.

The accession number for all reads used are: SRR1665023, SRR1665024, SRR1665025, SRR1665026, SRR1665027, SRR1665028, SRR6314253, SRR6314254, SRR6314255, SRR6314256, SRR6314257, SRR6314258, SRR6314259, SRR6314260, SRR6314261, SRR6314262, SRR6314263, SRR6314273, SRR6314274, SRR6314275, SRR6314276, SRR6314277, SRR6314278.

Funding Information
===================

This paper was supported by the following grants:

-   http://dx.doi.org/10.13039/501100000024Canadian Institutes of Health Research MOP-142475 to Nicanor González-Morales, Yu Shu Xiao, Matthew Aaron Schilling, Océane Marescal, Kuo An Liao.

-   http://dx.doi.org/10.13039/501100000024Canadian Institutes of Health Research PJT-155995 to Nicanor González-Morales, Yu Shu Xiao, Matthew Aaron Schilling, Océane Marescal, Kuo An Liao.

-   http://dx.doi.org/10.13039/501100000038Natural Sciences and Engineering Research Council of Canada RGPIN 2016-06793 to Nicanor González-Morales, Yu Shu Xiao, Matthew Aaron Schilling, Océane Marescal, Kuo An Liao.

We appreciate the help of Tuana Correia-Mesquita and Beili Hu in making transgenic flies. We thank the Bloomington Drosophila stock center, Vienna Drosophila Resource Center, and the Drosophila Genomics Resource Center for materials and the CIAN imaging facility for providing access to confocal microscopy. This work was supported by operating grants MOP-142475 and PJT-155995 from the Canadian Institutes of Health Research and by RGPIN 2016--06793 from the Natural Sciences and Engineering Research Council of Canada.

Additional information {#s5}
======================

No competing interests declared.

Conceptualization, Data curation, Software, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Writing---original draft, Writing---review and editing.

Investigation, Methodology.

Investigation, Methodology.

Investigation, Methodology.

Investigation, Methodology.

Conceptualization, Supervision, Funding acquisition, Writing---original draft, Writing---review and editing.

Additional files {#s6}
================

###### Detailed genotypes for all figures.

Data availability {#s7}
=================

All data generated or analysed during this study are included in the manuscript and supporting files.
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**Acceptance summary:**

Sarcomere formation during muscle development is a complex multi-step process that assembles a gigantic macromolecular machine, which will generate the force for future muscle contractions. Gonzalez-Morales and co-workers present a comprehensive, technically and intellectually sophisticated analysis of the function of Zasp proteins during sarcomere development using the *Drosophila* model. The authors discovered that the Z-disc associated alternatively spliced proteins (Zasps) regulate sarcomere diameter by setting the Z-disc diameter using a new mechanism of Zasp protein oligomerization: depending on presence or absence of multiple LIMdomains in the alternatively spliced Zasp isoforms, Zasp proteins can oligomerize and the Z-disc can grow to the desired diameter during muscle development. This work is a fundamental step ahead in the complex field of sarcomerogenesis and will be highly valuable to inform sarcomere development studies in other organisms and muscle types.

**Decision letter after peer review:**

Thank you for submitting your article \"Myofibril size is set by a finely tuned mechanism of protein aggregation in *Drosophila*\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Frank Schnorrer as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Anna Akhmanova as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

This manuscript presents a comprehensive, technically and intellectually sophisticated analysis of the members of the muscle actinin-associated LIM domain, PDZ domain family proteins, called Zasp proteins in controlling myofibril width in *Drosophila*. The authors use cellular, genetic and biochemical protein-protein interaction assays and developmental in vivo data to suggest that temporally differentially expressed long and short isoforms of the Zasp proteins control the size of the Z-disc in flight muscles. Mechanistically, the authors suggest a finely balanced interaction code of homo and heterodimers that depends on the differentially expressed LIM and ZM domains of the long, LIM carrying (growing) vs. short, devoid of LIM (blocking) isoforms.

All three reviewers agree that this work is a fundamental step ahead in the complicated field of Z-disc morphogenesis and will also be highly valuable to inform studies in other organisms and muscle types.

However, all reviewers suggest a number of essential points the authors need to address, some of which relate to the terminology used.

Essential revisions:

Terminology -- The terminology is often ambiguous and confusing.

1\) The term \"aggregation\" is unfortunate for describing macromolecular assemblies of Zasp proteins. Z-discs are very elaborate structures, which are highly regular. Hence, they are rather the opposite of an undefined aggregate.

The authors observe aggregate formation upon strong over-expression of Zasp. It is unclear whether these over-expressed wild-type Zasp proteins can be compared to pathological aggregates. The authors should use a term that clearly separates misfolded protein aggregates in myopathies (which do not trigger Z-disk formation) from the multi-molecular assemblies that may be involved in Z-disk formation, where folded domains form defined interactions between native proteins. Furthermore, it seems that these large \"aggregates\" only occur under over-expression and \"aggregates\" are *not* formed by Zasps expressed under the native promoters.

2)Title -- The title should be more explicit about myofibril width, and not size, as size can be sarcomere length as well. A possible amended title could be \"Myofibril diameter is set by a finely tuned mechanism of protein oligomerisation in *Drosophila*\".

The same ambiguity about Zasp and sarcomere size should be avoided in the text (e.g. subsection "Z-disc formation and growth is driven by multivalent aggregation of Zasp proteins", second paragraph).

3\) Multivalent refers to a domain that has multiple sites at which interactions can form. The authors present no evidence that an individual LIM domain is multivalent -- each one seems to form one distinct interaction. This term is therefore confusing.

Z-disc growth hypothesis --

4\) The current statement that the ratio of long to short Zasp isoforms control Z-disc diameter is over-stated and not strongly supported by the data throughout the paper. It is clear is that over-expression of Zasp52 long destroys the fibrils and generates large ectopic \'aggregates\' (Figure 1B). Overexpression of the short isoforms does not lead to aggregate formation, but is also does not strongly reduce myofibril width (rest of Figure 1).

Also Figure 6 does not fully support the authors\' hypothesis. It rather appears that an imbalance of the short to long isoforms results in a larger variation of myofibril width. For example over-expression of Zasp52-PP (short) causes some fibrils to be thinner but also many to be thicker, which is against the simple hypothesis. The same appears true in the *Zasp52^MI00979^*allele, the myofibrils in the image shown (Figure 6B) are very variable in width and seem to have a problem with running straight rather than being consistently thinner, at least if the image shown in Figure 6B is representative. Furthermore, the Zasp66 Zasp67 double mutants appear to result in many destroyed fibrils (Figure 7C) rather than in consistently thicker ones.

Generally, the authors use a very strong driver, Act88F-Gal4 to overexpress the Zasp isoforms. What happens with weaker drivers, such as *Mef2*. Are aggregates formed? Do the Z-discs change?

5\) It would be important to provide more molecular support that the *Zasp52^MI00979^*allele is indeed null for the long isoforms. Western Blots seem straight forward. Alternatively, the generation of clean CRISPR allele. Not being null might be a reason for the rather weak phenotype.

6\) The localisations of the long vs. short Zasp variants on the Z-disc in Figure 5F-H is very impressive. However, it is not clear from the Materials and methods how these data were acquired. Have the authors done sections, e.g. using a microtome, and imaged the slices in 3D including Z-plane information? The radial distribution of Zasp isoforms could be influenced by many technical factors. How was it ascertained that the same Z-disk plane was imaged and averaged? Please explain what thickness the transverse sections were and how they were imaged.

Is it possible to image both Zasp52 long and Zasp66-GFP at the same time in these sections to have an internal control? As antibodies are available, this should be feasible.

7\) Does increased or decreased Z-disc width change sarcomere length? Likely not, but it would be interesting see quantitative data.

8\) Please provide a data table with all the relevant measures used to make the graphs of the paper including animal numbers etc.
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Author response

> Essential revisions:
>
> Terminology -- The terminology is often ambiguous and confusing.
>
> 1\) The term \"aggregation\" is unfortunate for describing macromolecular assemblies of Zasp proteins. Z-discs are very elaborate structures, which are highly regular. Hence, they are rather the opposite of an undefined aggregate.
>
> The authors observe aggregate formation upon strong over-expression of Zasp. It is unclear whether these over-expressed wild-type Zasp proteins can be compared to pathological aggregates. The authors should use a term that clearly separates misfolded protein aggregates in myopathies (which do not trigger Z-disk formation) from the multi-molecular assemblies that may be involved in Z-disk formation, where folded domains form defined interactions between native proteins. Furthermore, it seems that these large \"aggregates\" only occur under over-expression and \"aggregates\" are not formed by Zasps expressed under the native promoters.

These are good points. We now use more specific language throughout, in particular changing sarcomere size to sarcomere diameter, and changing aggregation to oligomerization. In addition, we provide data showing that Z-disc overgrowth results in aggregate formation (Figure 1J and L), i.e., these two phenomena are linked by expression levels of Zasp52 growing isoforms: weak overexpression results in increased sarcomere diameter, strong overexpression results in aggregates.

> 2)Title -- The title should be more explicit about myofibril width, and not size, as size can be sarcomere length as well. A possible amended title could be \"Myofibril diameter is set by a finely tuned mechanism of protein oligomerisation in Drosophila\".
>
> The same ambiguity about Zasp and sarcomere size should be avoided in the text (e.g. subsection "Z-disc formation and growth is driven by multivalent aggregation of Zasp proteins", second paragraph).

We changed the title accordingly.

> 3\) Multivalent refers to a domain that has multiple sites at which interactions can form. The authors present no evidence that an individual LIM domain is multivalent -- each one seems to form one distinct interaction. This term is therefore confusing.

We meant Zasp growing isoforms are multivalent, they have multiple interaction sites (multiple, meaning more than one LIM domain). We adjusted the wording.

> Z-disc growth hypothesis --
>
> 4\) The current statement that the ratio of long to short Zasp isoforms control Z-disc diameter is over-stated and not strongly supported by the data throughout the paper. It is clear is that over-expression of Zasp52 long destroys the fibrils and generates large ectopic \'aggregates\' (Figure 1B). Overexpression of the short isoforms does not lead to aggregate formation, but is also does not strongly reduce myofibril width (rest of Figure 1).
>
> Also Figure 6 does not fully support the authors\' hypothesis. It rather appears that an imbalance of the short to long isoforms results in a larger variation of myofibril width. For example over-expression of Zasp52-PP (short) causes some fibrils to be thinner but also many to be thicker, which is against the simple hypothesis. The same appears true in the Zasp52^MI00979^ allele, the myofibrils in the image shown (Figure 6B) are very variable in width and seem to have a problem with running straight rather than being consistently thinner, at least if the image shown in Figure 6B is representative. Furthermore, the Zasp66 Zasp67 double mutants appear to result in many destroyed fibrils (Figure 7C) rather than in consistently thicker ones.
>
> Generally, the authors use a very strong driver, Act88F-Gal4 to overexpress the Zasp isoforms. What happens with weaker drivers, such as Mef2. Are aggregates formed? Do the Z-discs change?

We find that *Mef2*-Gal4 is a strong driver, similar to Act88F (and resulting in similar aggregates, data not shown). To test a weaker overexpression we used UH3-Gal4 that is a much weaker driver than Act88F and has a similar temporal expression profile.

Overexpression of Zasp52-PR using UH3-Gal4 does not form aggregates and instead results in bigger than normal Z-discs. We have added these results to Figure 1J-L.

*Zasp52^MI00979^* mutants have predominantly smaller Z-disc, with only a minimal increase in larger Z-discs (see quantification in Figure 6C). In contrast, *Zasp52^MI02988^*, which affects the small isoforms of Zasp52 have an increase in the proportion of big Z-discs, but not small ones. These two observations are consistent with our model.

The overexpression data is harder to fit into the model. As the reviewers pointed out, overexpression of blocking isoforms leads to a larger variation in Z-disc diameter rather than just an increase in small Z-discs. The important observation is that overexpression of any of the three blocking isoforms results in smaller discs and that this can be reverted if the ZM domain is mutated. Bigger Z-discs might result from the forced addition of Zasp proteins into the Z-disc independently of their role as blocking isoforms. Overexpression data are always somewhat artificial and not necessarily the exact opposite of the mutation. The Zasp66 and Zasp67 mutant phenotypes presented in Figure 7A-E are undoubtedly more convincing and confirm our model.

> 5\) It would be important to provide more molecular support that the Zasp52^MI00979^ allele is indeed null for the long isoforms. Western Blots seem straight forward. Alternatively, the generation of clean CRISPR allele. Not being null might be a reason for the rather weak phenotype.

We have already characterized the depletion of the long isoforms by western blotting in the Zasp^MI00979^ allele in Liao K., et al., 2016. Figure 6B). There appears to be a small amount of readthrough (Figure 6C), visible upon long exposure and increased loading of gel, indicating that all 3 alleles (02988, 07547, 00979) are strong hypomorphs.

> 6\) The localisations of the long vs. short Zasp variants on the Z-disc in Figure 5F-H is very impressive. However, it is not clear from the Materials and methods how these data were acquired. Have the authors done sections, e.g. using a microtome, and imaged the slices in 3D including Z-plane information? The radial distribution of Zasp isoforms could be influenced by many technical factors. How was it ascertained that the same Z-disk plane was imaged and averaged? Please explain what thickness the transverse sections were and how they were imaged.
>
> Is it possible to image both Zasp52 long and Zasp66-GFP at the same time in these sections to have an internal control? As antibodies are available, this should be feasible.

We used phalloidin staining as an internal control and we now include the counterstains as suggested (revised Figure 5). To detect specifically the long isoforms of Zasp52 we used a GFP protein trap allele \[Zasp52-ZCL\]. We have several antibodies for Zasp52 but they all recognize the N-terminal region which mostly labels the short isoforms. To image Zasp66 or Zasp67 we only have GFP trap alleles. Therefore, we cannot image the long isoforms of Zasp52 and Zasp66 at the same time.

We also added more details to the Materials and methods section and a supplementary figure to better explain how the images were obtained (Figure 5---figure supplement 1).

> 7\) Does increased or decreased Z-disc width change sarcomere length? Likely not, but it would be interesting see quantitative data.

*Zasp52^MI00979^* mutants are slightly shorter than the control. We don't have a clear explanation for this, sarcomere length regulation is a very complex matter and at this point it is unclear if Zasp plays a role or if these defects are indirect effects of perturbing Z-disc composition. We prefer not to include this data in the main text.
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> 8\) Please provide a data table with all the relevant measures used to make the graphs of the paper including animal numbers etc.

We have included excel files with all measurements (Source Data files).
